153 related articles for article (PubMed ID: 34941111)
21. Effectiveness and safety of different traditional Chinese medicines for Coronavirus disease 2019: A protocol for systematic review and network meta-analysis.
Huang B; Liu Y; Pi C; Yan S; Li F
Medicine (Baltimore); 2021 Aug; 100(31):e26676. PubMed ID: 34397799
[TBL] [Abstract][Full Text] [Related]
22. Network meta-analysis of heat-clearing and detoxifying oral liquid of Chinese medicines in treatment of children's hand-foot-mouth disease: A protocol for systematic review and meta-analysis.
Tang J; Zhang G; Xing J; Yu Y; Han T
Medicine (Baltimore); 2022 Feb; 101(5):e28778. PubMed ID: 35119042
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of Qi and Blood Tonic Chinese Medicines in the treatment of COVID-19: A protocol for systematic review and meta-analysis.
Yang F; Zhang X; Zhang Z; Lu H; Li J; Bai N; Geng N
Medicine (Baltimore); 2022 Dec; 101(49):e32136. PubMed ID: 36626419
[TBL] [Abstract][Full Text] [Related]
24. Clinical evidence of three traditional Chinese medicine drugs and three herbal formulas for COVID-19: A systematic review and meta-analysis of the Chinese population.
You LZ; Dai QQ; Zhong XY; Yu DD; Cui HR; Kong YF; Zhao MZ; Zhang XY; Xu QQ; Guan ZY; Wei XX; Zhang XC; Han SJ; Liu WJ; Chen Z; Zhang XY; Zhao C; Jin YH; Shang HC
J Integr Med; 2023 Sep; 21(5):441-454. PubMed ID: 37596131
[TBL] [Abstract][Full Text] [Related]
25. The effectiveness and safety of traditional Chinese medicine for the treatment of children with COVID-19.
Li Y; Bi L; Li Y; Hu X; Wang Q; Liang X; Yu X; Dong L; Xie Q
Medicine (Baltimore); 2020 Jul; 99(30):e21247. PubMed ID: 32791699
[TBL] [Abstract][Full Text] [Related]
26. Traditional Chinese medicine Lianhua Qingwen for treating COVID-19: A protocol for a meta-analysis and systematic review of randomized controlled trials.
Li S; Zhang J; Li F; Mao A; Li Y; Zhao C; Hu X; Li F; Wang W
Medicine (Baltimore); 2021 Jan; 100(2):e24204. PubMed ID: 33466197
[TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy and safety of traditional Chinese patent medicine for cognitive dysfunction in diabetic cognitive dysfunction: A protocol for systematic review and Bayesian network meta-analysis.
Wang K; Jiang Z; Yu X; Shao Y; Liu H; Wu S; Kong L; Wang Z
Medicine (Baltimore); 2022 Mar; 101(10):e28946. PubMed ID: 35451386
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of oral traditional Chinese patent medicine in treatment of liver stagnation and spleen deficiency of depression: A protocol for systematic review.
Yu Y; Zhang G; Han T; Huang H
Medicine (Baltimore); 2020 Feb; 99(7):e19142. PubMed ID: 32049837
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy and safety of traditional Chinese patent medicine for NAFLD in childhood or adolescence: A protocol for a Bayesian network meta analysis.
Sun Y; Tan Z; Jiang Z; Li M; Wang W; Huang Y; Sun J
Medicine (Baltimore); 2021 Jan; 100(3):e24277. PubMed ID: 33546051
[TBL] [Abstract][Full Text] [Related]
30. Effect of Fufang Biejia Ruangan Tablet on lowering biochemical and virological parameters of hepatic fibrosis in patients with chronic hepatitis B: Protocol for a systematic review and meta-analysis of randomized controlled trials and cohort studies.
Huang C; Shen D; Sun S; Huang Y; Xin Y; Luo H; Chen Y; Zhou Z; Liu F; Chen X
Medicine (Baltimore); 2019 Apr; 98(17):e15297. PubMed ID: 31027094
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of acupuncture combined with Chinese herbal medicine traditional Chinese medicine for poststroke cognitive impairment: A protocol for a systematic review and meta-analysis.
Wang Y; Guo S; Xiao ML; Zhang H
Medicine (Baltimore); 2022 Mar; 101(9):e29019. PubMed ID: 35244083
[TBL] [Abstract][Full Text] [Related]
32. Comparison of efficacy and safety of traditional Chinese patent medicine in the treatment of vitiligo in children or adults: A protocol for systematic review and network meta-analysis.
Yang M; Du M; Tang Z; Han G; Dong W; Chen Z; Song Y
Medicine (Baltimore); 2021 Mar; 100(11):e24878. PubMed ID: 33725959
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of oral traditional Chinese patent medicine for chronic cerebral circulation insufficiency patients: A protocol for a systematic review and network meta-analysis.
Xu Z; Feng X; Li L; Hu Z; Xiao Y; Jin G; Liao W
Medicine (Baltimore); 2019 Jul; 98(27):e16175. PubMed ID: 31277122
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of efficacy of different combination therapies of α-receptor blockers and traditional Chinese medicine external therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: Bayesian network meta-analysis.
Zhang K; Zhang Y; Hong S; Cao Y; Liu C
PLoS One; 2023; 18(4):e0280821. PubMed ID: 37079509
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 4 kinds of traditional Chinese medicine injections to assist in improving clinical indicators of patients with idiopathic pulmonary fibrosis: A systematic review and network meta-analysis.
Wu X; Li W; Qin Z; Luo Z; Xue L; Chen Y
Medicine (Baltimore); 2022 Nov; 101(47):e31877. PubMed ID: 36451506
[TBL] [Abstract][Full Text] [Related]
36. Internal treatment in traditional Chinese medicine for patients with COVID-19: A protocol for systematic review and meta-analysis.
Zhang M; Huang J; Wu X; Lv L; Huang A; Zhu S
Medicine (Baltimore); 2020 Dec; 99(51):e23739. PubMed ID: 33371129
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis.
Zhang X; Cao D; Liu J; Zhang Q; Liu M
Medicine (Baltimore); 2020 Jul; 99(30):e21404. PubMed ID: 32791754
[TBL] [Abstract][Full Text] [Related]
38. Traditional Chinese medicine for oral squamous cell carcinoma: A Bayesian network meta-analysis protocol.
Wang D; Duan X; Zhang Y; Meng Z; Wang J
Medicine (Baltimore); 2020 Oct; 99(43):e22955. PubMed ID: 33120858
[TBL] [Abstract][Full Text] [Related]
39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of Banxia Xiexin Decoction as a complementary treatment for gastric cancer: A protocol for systematic review and meta-analysis.
Zhang M; Huang W; Yuan D
Medicine (Baltimore); 2021 Apr; 100(17):e25747. PubMed ID: 33907170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
